This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Gold in rheumatoid arthritis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

When using gold in RA, the following should be noted:

  • therapeutic effects of gold salts develop slowly - maximum response is reached after 4-6 months treatment

  • i.m. gold:
    • a 10mg test dose is first given - this is necessary to exclude hypersensitivity
    • test dose followed by 50mg i.m. weekly until response occurs
    • change in dosage interval is undertaken 3-monthly because of lead-time in clinical response to change in dose
    • if no response after 1000mg total dose then treatment should be discontinued
    • if response to gold i.m. then:
      • monthly doses while arthritis persists
      • maintain for 5 years after complete remission

  • oral gold:
    • dose:
      • initial 3mg/daily for 4 weeks
      • maintenance 3mg bd
      • if no response to can be increased to 3mg tds

  • oral preparation has fewer side effects than i.m.
  • most common side effect is diarrhoea

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.